Laurion Capital Management LP Electro Core, Inc. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.18 $84,683 - $107,448	-91,058 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.62 - $3.05 $95,486 - $179,773	-58,942 Reduced 39.29%	91,058 $188,000
Q3 2020 Nov 13, 2020	BUY	$0.8 - $2.33 $120,000 - $349,500	150,000 New	150,000 $260,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $427M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.